Press Release

NOVOS Launches Free AI-based Biological Age Test; Most Accurate on Market to Date

Available in the NOVOS Life app, with additional, personalized features to support your longevity lifestyle: Lifestyle score and recommendations, daily actions, and AI chat guidance

New York, NY / May 29, 2024 / NOVOS

NOVOS, the leading provider of longevity solutions designed to promote healthy aging and extend the human lifespan, today announced the launch of a free, peer-reviewed Biological Age test. The AI-based test is the most accurate, questionnaire-based biological age clock available to date, outperforming most blood-based tests. The clock is trained using XAI methods (explainable artificial intelligence) and based on health and lifestyle data from over 47,000 people aged 18-80+.

NOVOS’ free Biological Age test is available in NOVOS Life, the brand’s first, free mobile app (Download iOS | Download Android); simply complete the lifestyle survey at sign up to get started. App users will also gain access to an actionable longevity guide with personalized lifestyle recommendations and daily actions that aim to extend their healthspan and decrease their biological age, based on the latest longevity research.

The test and supporting features allow individuals to better understand the factors that impact the aging process and make informed decisions that slow down their biological clock and improve long-term health. By removing common barriers to these services that often require high-cost, blood-based tests, NOVOS aims to make adopting a longevity lifestyle easy and accessible to people in a way others haven’t to date.

Understanding your test results: A biological age lower than one’s chronological age indicates a healthier state. A higher biological age suggests an increased risk of age-related diseases and the need for certain lifestyle adjustments. For both, there are always opportunities for further improvement, which NOVOS Life helps identify

In addition to the Biological Age test, the following NOVOS Life features further guide users on their lifelong journey to healthy aging:

  • Longevity Profile: Users complete the questionnaire that explores their daily habits, health practices, diet, and more, designed by longevity experts.
  • Lifestyle Score: A score is then calculated out of 100 and reflects how well-aligned one’s lifestyle is to longevity based on the latest scientific insights.
  • Community Ranking: Compare one’s longevity to their community and others more broadly using a percentile-based approach; creating an insightful way to gauge progress and engage in shared longevity journeys.
  • Personalized Recommendations: Specific suggestions to enhance health and fill key gaps based on questionnaire results. Such as reducing sitting time or boosting omega-3 intake. Each recommendation cites supporting scientific article(s).
  • Daily Actions: Making the recommendations actionable, such as purchasing a standing desk or setting a reminder to stand for two minutes hourly. Users can customize actions to what works best for them.
  • AI Chat: Trained by NOVOS to answer general longevity questions from best diet to suggested exercises. Future iterations will offer proactive support.

“The longevity movement has gained traction among enthusiasts, but the real, daily practice of it is still too gatekept,” said Chris Mirabile, Founder and CEO of NOVOS. “As a Public Benefit Corporation, we want to give people free tools that they can use to live healthier for longer. Everyone deserves to know their biological age and how certain lifestyle changes can slow it. While the process can feel overwhelming, NOVOS Life makes it simple to make immediate improvements based on scientific recommendations people can trust.”

The test is powered by ENABL Age, a novel algorithm and epigenetic clock built by top experts in longevity, Su-In Lee, PhD and Matt Kaeberlein, PhD, and implemented by NOVOS’ Director of R&D, Diogo Barardo, PhD. Combining ML models with XAI methods, the algorithm can produce accurate biological age outputs and predict age-related outcomes based on a questionnaire about one’s lifestyle and health behaviors.

“ENABL Age represents progress in the longevity field, applying AI to better understand aging and notably, in estimating it accurately for specific individuals,” said Diogo Barardo, PhD, Director of R&D at NOVOS. “By offering a consumer-facing, actionable version of the ENABL Age algorithm, NOVOS is advancing the practical application of biological age clocks.”

Co-author and longevity researcher, Matt Kaeberlein, said “I appreciate that NOVOS continues making a legitimate effort to further the field with scientifically valid approaches, and is making longevity accessible to the masses by promoting free lifestyle interventions that all of us can adopt.”

NOVOS also offers a for-purchase blood-based test, NOVOS Age, which leverages the third-generation, and most accurate, DunedinPACE clock for those ready to dive deeper into the science as well as a suite of longevity supplements designed to help slow the pace of aging.


NOVOS was founded in 2018 by anti-aging and longevity expert Chris Mirabile with a team of esteemed longevity and aging scientists dedicated to unlocking access to knowledge and products that address the 12 hallmarks of aging. The company’s breakthrough product line and scientific developments have been linked to fostering healthy aging with evidence that it can contribute to improvements in human longevity through formulations, tests, and guidance. As a Public Benefit Corporation, NOVOS actively contributes to nonprofit organizations, such as the Life Extension Advocacy Foundation (LEAF) as well as accredited university labs that are catalyzing the uncovering of breakthrough discoveries in anti-senescence and longevity. The company also provides free digital tools and content sharing the latest insights and information about the aging process for free, uniting people to live longer, healthier, and more youthful lives

Press Contact Jack Taylor
Jack Taylor PR
Get the latest health and fitness industry news

Keep up with industry news, trends, investment activity, and job openings — in one weekly newsletter.

    No thanks.